Phoenix Names New CEO
SHINE Technologies named Tom D’Orazio as the CEO of Phoenix, the company announced recently. According to a release, D’Orazio has more than two decades of experience in sales leadership roles…
Category Archives: Biotech
Immuto Scientific Awarded $2.5M SBIR Grant
Immuto Scientific has been awarded a $2.5 million Phase II SBIR grant from the National Institutes of Health (NIH), the company announced recently. According to a release, the grant will…
SHINE Files Drug Master File With FDA
SHINE Technologies has submitted a Drug Master File (DMF) with the U.S. Food and Drug Administration for non-carrier-added lutetium-177 (Lu-177) chloride, the company announced recently. According to a release, the…
SpayVac Receives Investment from BrightStar
BrightStar Wisconsin Foundation announced recently that it has invested in SpayVac, an animal sterilization technology company. “Issues with feral animals have reached crisis level in parts of the world and…
NorthStar Promotes New President
NorthStar Medical Technologies promoted Dr. Frank Scholz as its new President and Chief Operating Officer, the organization announced recently. “I want to congratulate Frank Scholz on this well-deserved promotion to…
SHINE Adds Two Board Members
SHINE Technologies announced recently that Holli C. Ladhani and Janet S. Wong have joined its board of directors. “We are excited to bring these two highly talented individuals to our…
Promega Launches Post-Doc Research Program
Promega is launching a post-doctoral research program for life science researchers to explore new ideas for genome engineering technology, the company announced today. AstraZeneca will provide mentoring support in the three-year…
Promega, FCDI to Collaborate
Promega and FUJIFILM Cellular Dynamics Inc. announced recently that they will partner to advance novel assay development for drug discovery. According to a release, the multi-year licensing agreement will integrate…
SHINE to Supply ImaginAb
SHINE Technologies announced recently that it will supply ImaginAb Inc., a global biotechnology company focused on developing immuno-oncology imaging agents and therapeutic radiopharmaceuticals, with lutetium-177 (Lu-177) to support the company’s…
JangoBio Develops Therapy for Hormone Replacement
JangoBio announced today that it developed a sustainable stem cell-based therapy to replenish hormones back to youthful levels. According to a release, JangoBio scientists were successful in using adult stem…
